Clinical Trials Browser

Phase 1/2 × Completed × Epstein-Barr Virus Infections × Clear all

NCT02580539 2025-05-14

EBV-TCL-01

Phase 1/2 Completed

Lymphoma, Epstein-Barr Virus Infections

NCT00478465 2022-05-27

Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

Phase 1/2 Completed

Fatigue, Herpes Simplex, Fatigue Syndrome, Chronic, Epstein-Barr Virus Infections

NCT02496676 2022-03-02

Magnesium Supplementation in People With XMEN Syndrome

Phase 1/2 Completed

8 enrolled 7 charts

Primary Immunodeficiency Diseases, Infections, Neoplasms, Epstein-Barr Virus Infections

NCT02227641 2020-12-14

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Phase 1/2 Completed

Virus Diseases, Epstein-Barr Virus Infections

NCT02000817 2019-06-24

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

Phase 1/2 Completed

30 enrolled 21 charts

Cytokine Release Syndrome, Diabetes Mellitus, Diabetes Mellitus, Type 1, Epstein-Barr Virus Infections

NCT01570283 2019-05-30

ARMS

Phase 1/2 Completed

21 enrolled 10 charts

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT00711035 2016-04-26

CHALLAH

Phase 1/2 Completed

Adenoviridae Infections, Epstein-Barr Virus Infections

NCT00274404 2011-10-27

Controlled Trial of Valacyclovir in Infectious Mononucleosis

Phase 1/2 Completed

Infectious Mononucleosis, Epstein-Barr Virus Infections